You are here

Exagen

Poor fourth quarter mars strong year for medtech floats

Poor fourth quarter mars strong year for medtech floats

EP Vantage

Smile Direct Club

Silk Road Medical

Adaptive Biotechnologies

Shockwave Medical

Castle Biosciences

Flag link:

The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck

The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck

Yahoo/Benzinga

oral semaglutide

Kodiak Sciences

MeiraGTx Holdings

IGM Biosciences

Arrowhead Pharmaceuticals

Lexicon Pharmaceuticals

vTv Therapeutics

Flag link:

Exagen Files for $57 Million IPO

Exagen Files for $57 Million IPO

CP Wire

Flag link:

Exagen Files for $57 Million IPO

Flag link: